Quality and standards

WHO norms and standards

WHO has played a key role for over 50 years in establishing the WHO International Biological Reference Preparations and in developing WHO guidelines and recommendations on the production and control of biological products and technologies. These norms and standards are based on wide scientific consultation and on international consensus and are intended to assist WHO Member States in ensuring the consistent quality and safety of biological medicines and related in vitro biological diagnostic tests worldwide. The Organization develops this work through its biological programme and the WHO Expert Committee on Biological Standardization. This also involves close collaboration with the international scientific and professional communities, regional and national regulatory authorities, manufacturers and expert laboratories worldwide.

RELATED LINKS

WHO HPV LabNet - Newsletter 05
Download [pdf 437kb]

WHO Workshop in Training Performance of Potency Testing and Lot Release of Human Papillomavirus (HPV) Vaccines
NIBSC, UK, 11-15 May 2009
Download [pdf 136kb]

Further H1N1 specific update of TRS941, Annex 5
Download [pdf 145kb]

H1N1 specific-update of TRS941, Annex 5
Download [pdf 162kb]

Proposed Guidelines: Regulatory Preparedness for Human pandemic Influenza Vaccines
Download [pdf 690kb]

WHO 2010 Human Papillomavirus (HPV) LabNet Training Workshop on HPV Genotyping and HPV Serology Laboratory Performance
15-18 March 2010, CHUV, Lausanne, Switzerland

Informal Consultation on Revision of WHO Recommendations to assure the Quality, Safety and efficacy of Yellow Fever Vaccines
27-28 April 2010, WHO, Geneva, Switzerland

Immunization, Vaccines and Biologicals
World Health Organization (WHO)
Avenue Appia
CH-1211 Geneva